ZNF683+CD8+ T cells have been described as a specific T cell population that responds to anti‐PD‐1 treatments and expresses genes linked to cytotoxicity, tissue resident memory, and T cell exhaustion.[72, 73] The source of tumor‐infiltrating CD8+ T cells in this study has also been identified as ZNF683+ CD8+ T cells, which have the potential to become activated and develop into effector T cells. The gene discussed is CD8A; the disease is neoplasm.